Izotropic Corporation
Izotropic Corporation IZOZF Peers
See (IZOZF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IZOZF | $0.22 | +0.02% | 13.5M | -7.43 | -$0.03 | N/A |
| LZAGY | $67.96 | -0.93% | 49B | 62.93 | $1.08 | +0.75% |
| LZAGF | $689.35 | +1.08% | 48.5B | 63.71 | $10.82 | +0.42% |
| WUXAY | $8.37 | +0.70% | 24.9B | 15.50 | $0.54 | +0.75% |
| WUXIF | $7.34 | N/A | 21.1B | 13.59 | $0.54 | +2.54% |
| BMXMF | $129.73 | +0.00% | 15.3B | 31.41 | $4.13 | +0.71% |
| ERFSF | $62.67 | -2.97% | 11B | 26.56 | $2.36 | +1.68% |
| SKHCF | $17.76 | -1.88% | 8.5B | 24.33 | $0.73 | +3.95% |
| SKHHY | $17.16 | +0.26% | 8.2B | 23.18 | $0.74 | +3.93% |
| DSRLF | $104.69 | +0.00% | 5.6B | 26.57 | $3.94 | +1.30% |
Stock Comparison
IZOZF vs LZAGY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, LZAGY has a market cap of 49B. Regarding current trading prices, IZOZF is priced at $0.22, while LZAGY trades at $67.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas LZAGY's P/E ratio is 62.93. In terms of profitability, IZOZF's ROE is +0.47%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, IZOZF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs LZAGF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, LZAGF has a market cap of 48.5B. Regarding current trading prices, IZOZF is priced at $0.22, while LZAGF trades at $689.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas LZAGF's P/E ratio is 63.71. In terms of profitability, IZOZF's ROE is +0.47%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, IZOZF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs WUXAY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, WUXAY has a market cap of 24.9B. Regarding current trading prices, IZOZF is priced at $0.22, while WUXAY trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas WUXAY's P/E ratio is 15.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, IZOZF is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs WUXIF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, WUXIF has a market cap of 21.1B. Regarding current trading prices, IZOZF is priced at $0.22, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, IZOZF's ROE is +0.47%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, IZOZF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BMXMF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BMXMF has a market cap of 15.3B. Regarding current trading prices, IZOZF is priced at $0.22, while BMXMF trades at $129.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BMXMF's P/E ratio is 31.41. In terms of profitability, IZOZF's ROE is +0.47%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, IZOZF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ERFSF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ERFSF has a market cap of 11B. Regarding current trading prices, IZOZF is priced at $0.22, while ERFSF trades at $62.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ERFSF's P/E ratio is 26.56. In terms of profitability, IZOZF's ROE is +0.47%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, IZOZF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SKHCF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SKHCF has a market cap of 8.5B. Regarding current trading prices, IZOZF is priced at $0.22, while SKHCF trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SKHCF's P/E ratio is 24.33. In terms of profitability, IZOZF's ROE is +0.47%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, IZOZF is less volatile compared to SKHCF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SKHHY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SKHHY has a market cap of 8.2B. Regarding current trading prices, IZOZF is priced at $0.22, while SKHHY trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SKHHY's P/E ratio is 23.18. In terms of profitability, IZOZF's ROE is +0.47%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, IZOZF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs DSRLF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, DSRLF has a market cap of 5.6B. Regarding current trading prices, IZOZF is priced at $0.22, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas DSRLF's P/E ratio is 26.57. In terms of profitability, IZOZF's ROE is +0.47%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, IZOZF is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs HNGZY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, HNGZY has a market cap of 4.5B. Regarding current trading prices, IZOZF is priced at $0.22, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, IZOZF's ROE is +0.47%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, IZOZF is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs VIMGF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, IZOZF is priced at $0.22, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, IZOZF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MRCHF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, IZOZF is priced at $0.22, while MRCHF trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MRCHF's P/E ratio is 62.35. In terms of profitability, IZOZF's ROE is +0.47%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, IZOZF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IDGXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, IZOZF is priced at $0.22, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, IZOZF is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs EDTXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, EDTXF has a market cap of 179.6M. Regarding current trading prices, IZOZF is priced at $0.22, while EDTXF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas EDTXF's P/E ratio is -10.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, IZOZF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs AMCY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, IZOZF is priced at $0.22, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas AMCY's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to AMCY's ROE of N/A. Regarding short-term risk, IZOZF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs NNGRF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, IZOZF is priced at $0.22, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, IZOZF's ROE is +0.47%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, IZOZF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ATLN Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ATLN has a market cap of 155.9M. Regarding current trading prices, IZOZF is priced at $0.22, while ATLN trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ATLN's P/E ratio is -0.72. In terms of profitability, IZOZF's ROE is +0.47%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, IZOZF is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs CORBF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, CORBF has a market cap of 133.9M. Regarding current trading prices, IZOZF is priced at $0.22, while CORBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas CORBF's P/E ratio is 3.03. In terms of profitability, IZOZF's ROE is +0.47%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, IZOZF is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs THOXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, IZOZF is priced at $0.22, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas THOXF's P/E ratio is -14.40. In terms of profitability, IZOZF's ROE is +0.47%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, IZOZF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs DIUXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, IZOZF is priced at $0.22, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, IZOZF's ROE is +0.47%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, IZOZF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ANPCF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, IZOZF is priced at $0.22, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, IZOZF's ROE is +0.47%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, IZOZF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs TIHE Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, IZOZF is priced at $0.22, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas TIHE's P/E ratio is 0.32. In terms of profitability, IZOZF's ROE is +0.47%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, IZOZF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BIOGF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, IZOZF is priced at $0.22, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, IZOZF's ROE is +0.47%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, IZOZF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs PCNEF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, IZOZF is priced at $0.22, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, IZOZF's ROE is +0.47%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, IZOZF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs PFGTF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, IZOZF is priced at $0.22, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, IZOZF's ROE is +0.47%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, IZOZF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs CLIFF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, IZOZF is priced at $0.22, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, IZOZF's ROE is +0.47%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, IZOZF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BIOQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BIOQ has a market cap of 40.2M. Regarding current trading prices, IZOZF is priced at $0.22, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BIOQ's P/E ratio is 15.85. In terms of profitability, IZOZF's ROE is +0.47%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, IZOZF is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ANPCY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ANPCY has a market cap of 35.5M. Regarding current trading prices, IZOZF is priced at $0.22, while ANPCY trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ANPCY's P/E ratio is -1.20. In terms of profitability, IZOZF's ROE is +0.47%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, IZOZF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SNANF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SNANF has a market cap of 29.3M. Regarding current trading prices, IZOZF is priced at $0.22, while SNANF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SNANF's P/E ratio is -13.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, IZOZF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IMMVF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, IZOZF is priced at $0.22, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, IZOZF's ROE is +0.47%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, IZOZF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs PCHM Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, PCHM has a market cap of 20.8M. Regarding current trading prices, IZOZF is priced at $0.22, while PCHM trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas PCHM's P/E ratio is -0.02. In terms of profitability, IZOZF's ROE is +0.47%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, IZOZF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs VILGF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, IZOZF is priced at $0.22, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas VILGF's P/E ratio is -0.30. In terms of profitability, IZOZF's ROE is +0.47%, compared to VILGF's ROE of N/A. Regarding short-term risk, IZOZF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BMKDF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BMKDF has a market cap of 19.7M. Regarding current trading prices, IZOZF is priced at $0.22, while BMKDF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BMKDF's P/E ratio is -21.72. In terms of profitability, IZOZF's ROE is +0.47%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, IZOZF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs PMSNF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, IZOZF is priced at $0.22, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, IZOZF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ABDXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, IZOZF is priced at $0.22, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, IZOZF's ROE is +0.47%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, IZOZF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MXDHF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, IZOZF is priced at $0.22, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, IZOZF's ROE is +0.47%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, IZOZF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs LDXHF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, LDXHF has a market cap of 7.5M. Regarding current trading prices, IZOZF is priced at $0.22, while LDXHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas LDXHF's P/E ratio is -1.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, IZOZF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs VRCDF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, IZOZF is priced at $0.22, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, IZOZF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SQIDF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, IZOZF is priced at $0.22, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, IZOZF's ROE is +0.47%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, IZOZF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SLDX Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, IZOZF is priced at $0.22, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SLDX's P/E ratio is -0.01. In terms of profitability, IZOZF's ROE is +0.47%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, IZOZF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs AVCRF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, AVCRF has a market cap of 4.6M. Regarding current trading prices, IZOZF is priced at $0.22, while AVCRF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas AVCRF's P/E ratio is -4.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, IZOZF is more volatile compared to AVCRF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs TDSGF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, TDSGF has a market cap of 4.3M. Regarding current trading prices, IZOZF is priced at $0.22, while TDSGF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas TDSGF's P/E ratio is -1.45. In terms of profitability, IZOZF's ROE is +0.47%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, IZOZF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs RNVA Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, IZOZF is priced at $0.22, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas RNVA's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, IZOZF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs JMPHF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, IZOZF is priced at $0.22, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, IZOZF's ROE is +0.47%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, IZOZF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs GNTLF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, IZOZF is priced at $0.22, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, IZOZF's ROE is +0.47%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, IZOZF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IDXG Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IDXG has a market cap of 3.6M. Regarding current trading prices, IZOZF is priced at $0.22, while IDXG trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IDXG's P/E ratio is 3.24. In terms of profitability, IZOZF's ROE is +0.47%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, IZOZF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SZLSF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SZLSF has a market cap of 3.6M. Regarding current trading prices, IZOZF is priced at $0.22, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, IZOZF's ROE is +0.47%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, IZOZF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ICBU Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ICBU has a market cap of 2.9M. Regarding current trading prices, IZOZF is priced at $0.22, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ICBU's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, IZOZF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IBXXF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, IZOZF is priced at $0.22, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, IZOZF's ROE is +0.47%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, IZOZF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IVRO Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IVRO has a market cap of 1.4M. Regarding current trading prices, IZOZF is priced at $0.22, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IVRO's P/E ratio is -0.78. In terms of profitability, IZOZF's ROE is +0.47%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, IZOZF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs NSTM Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, NSTM has a market cap of 1.4M. Regarding current trading prices, IZOZF is priced at $0.22, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas NSTM's P/E ratio is -0.50. In terms of profitability, IZOZF's ROE is +0.47%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, IZOZF is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs DIGP Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, IZOZF is priced at $0.22, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas DIGP's P/E ratio is -1.04. In terms of profitability, IZOZF's ROE is +0.47%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, IZOZF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IDTA Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IDTA has a market cap of 970.9K. Regarding current trading prices, IZOZF is priced at $0.22, while IDTA trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IDTA's P/E ratio is 2.40. In terms of profitability, IZOZF's ROE is +0.47%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, IZOZF is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs SCRSF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, SCRSF has a market cap of 857K. Regarding current trading prices, IZOZF is priced at $0.22, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, IZOZF's ROE is +0.47%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, IZOZF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs EPGNF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, IZOZF is priced at $0.22, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, IZOZF's ROE is +0.47%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, IZOZF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MBGNF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, IZOZF is priced at $0.22, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, IZOZF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs NVTAQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, IZOZF is priced at $0.22, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, IZOZF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs RSHN Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, RSHN has a market cap of 81.7K. Regarding current trading prices, IZOZF is priced at $0.22, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas RSHN's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, IZOZF is less volatile compared to RSHN. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ARYC Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, IZOZF is priced at $0.22, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ARYC's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, IZOZF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs HCLC Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, IZOZF is priced at $0.22, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas HCLC's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, IZOZF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MEDVF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, IZOZF is priced at $0.22, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, IZOZF's ROE is +0.47%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, IZOZF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs CHHL Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, IZOZF is priced at $0.22, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas CHHL's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, IZOZF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs IHTI Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, IZOZF is priced at $0.22, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas IHTI's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, IZOZF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MEDD Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, IZOZF is priced at $0.22, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MEDD's P/E ratio is -0.01. In terms of profitability, IZOZF's ROE is +0.47%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, IZOZF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs TOMDF Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, IZOZF is priced at $0.22, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas TOMDF's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, IZOZF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs CGNH Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, IZOZF is priced at $0.22, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas CGNH's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, IZOZF is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ABMC Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, IZOZF is priced at $0.22, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ABMC's P/E ratio is 0.01. In terms of profitability, IZOZF's ROE is +0.47%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, IZOZF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs RGDXQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, IZOZF is priced at $0.22, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, IZOZF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs DMTKQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, IZOZF is priced at $0.22, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, IZOZF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs GWHP Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, IZOZF is priced at $0.22, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas GWHP's P/E ratio is -0.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, IZOZF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs CYPS Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, CYPS has a market cap of 811. Regarding current trading prices, IZOZF is priced at $0.22, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas CYPS's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to CYPS's ROE of N/A. Regarding short-term risk, IZOZF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs ROSGQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, IZOZF is priced at $0.22, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, IZOZF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BIOCQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, IZOZF is priced at $0.22, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, IZOZF's ROE is +0.47%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, IZOZF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs HTGMQ Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, IZOZF is priced at $0.22, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, IZOZF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs OPGX Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, OPGX has a market cap of 17. Regarding current trading prices, IZOZF is priced at $0.22, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas OPGX's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, IZOZF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs MRPS Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, MRPS has a market cap of 0. Regarding current trading prices, IZOZF is priced at $0.22, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas MRPS's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to MRPS's ROE of N/A. Regarding short-term risk, IZOZF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs AGHC Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, AGHC has a market cap of 0. Regarding current trading prices, IZOZF is priced at $0.22, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas AGHC's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, IZOZF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs BGNX Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, BGNX has a market cap of 0. Regarding current trading prices, IZOZF is priced at $0.22, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas BGNX's P/E ratio is N/A. In terms of profitability, IZOZF's ROE is +0.47%, compared to BGNX's ROE of N/A. Regarding short-term risk, IZOZF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.
IZOZF vs EPGNY Comparison
IZOZF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IZOZF stands at 13.5M. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, IZOZF is priced at $0.22, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IZOZF currently has a P/E ratio of -7.43, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, IZOZF's ROE is +0.47%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, IZOZF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for IZOZF.